In a primary immune response a signal from interleukin 2 (IL-2) induces B lymphocytes to express the gene for the IgM joining component, the J chain. The signaling mechanism was pursued in this study by examining the J-chain gene S' flanking region for regulatory sequences and interacting nuclear factors. The analyses identified a major control region located between -75 and -45 that encodes two adjacent elements: a T-rich sequence (JA) containing a single positive regulatory motif and an A+G-rich sequence (JB) containing overlapping positive and negative regulatory motifs. Dissection of the two elements indicated that the bifunctional JB sequence is the likely target of the IL-2 signal. The evidence was based on findings that (i) JB activity correlated with J-chain gene transcription-i.e., JB acts as a repressor in J-chain-silent B cells and as an activator in J-chain-expressing cells, and (ii) JB activator function is mediated by a B-cell-specific nuclear protein, NF-JB, that exhibits an IL-2-responsive binding pattern.The synthesis of J chain by B lymphocytes has several features that make it an attractive model for analyzing the mechanism of lymphokine signaling. First, the expression of J chain is developmentally regulated at the transcriptional level (1). The gene remains silent during the early antigenindependent stages of B-lymphocyte differentiation and becomes activated only during a primary immune response when the J-chain product is used for the assembly and secretion of pentamer IgM antibody (2). Second, the extracellular cues for J-chain gene activation are known; they are provided by either of two lymphokines-interleukin 2 (IL-2) or interleukin 5 (IL-5) (3, 4)-that are secreted by antigenactivated T-helper cells. Finally, and most importantly, the activation events can be reproduced under defined conditions in vitro; a cloned murine B-cell line, BCL1, can be stimulated to transcribe the J-chain gene by treatment with physiological doses of recombinant IL-2 (5) and/or recombinant .By taking advantage of these features, some progress has been made in defining the mechanism of IL-2 signaling. Analyses of signal input have established that the J-chain response is initiated by IL-2 binding to high-affinity IL-2 receptors expressed by antigen-activated B cells (6) and their counterpart BCL1 cells (7). The 75-kDa component of the bimolecular receptor then delivers the IL-2 message to a relay system within the cell (7,8). Although the relay system has yet to be completely defined, two candidates for early events in the pathway have recently been described. One is a tyrosine kinase that is associated with the IL-2 receptor (9-11) and the other is a glycosylated form of phosphatidylinositol that is rapidly hydrolyzed in response to IL-2 to generate two potential second messengers (12, 13).Analyses of IL-2 signal outcome have shown that transcription of the J-chain gene correlates with chromatin changes in the 5' region. A single nuclease hypersensitive site is coinduced with J-chain gene expression ...